Rapid Screening of New Psychoactive Substances Using pDART-QqQ-MS
Journal of the American Society for Mass Spectrometry · 2024
DOI: 10.1021/jasms.4c00124 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Society for Mass Spectrometry, 2024. Verfasst von Wei-Hsin Hsu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, National Taiwan University, Taipei 10617, Taiwan. Hauptthemen laut MEDLINE: Psychotropic Drugs, Substance Abuse Detection, Illicit Drugs. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Taiwan University Hospital, Ministry of Science and Technology, Taiwan, Taipei City Hospital.
Abstract (Originalsprache)
Drug abuse is a severe social problem worldwide. Particularly, the issue of new psychoactive substances (NPSs) have increasingly emerged. NPSs are structural or functional analogs of traditional illicit drugs, such as cocaine, cannabis, and amphetamine; these molecules provide the same or more severe neurological effects. Usually, immunoassays are utilized in the preliminary screening method. However, NPSs have poor detectability in commercially available immunoassay kits. Meanwhile, various chromatography combined with the mass spectrometry platform have been developed to quantify NPSs. Still, a significant amount of time and resources are required during these procedures. Therefore, we established a rapid analytical platform for NPSs employing paper-loaded direct analysis in real time triple quadrupole mass spectrometry (pDART-QqQ-MS). We implemented this platform for the semiquantitative analysis of forensic drug tests in urine. This platform significantly shrinks the analytical time of a single sample within 30 s and requires a low volume of the specimen. The platform can detect 21 NPSs in urine mixtures at a lower limit of qualification of concentration ranging from 20 to 75 nanograms per milliliter (ng mL-1) and is lower than the cutoff value of currently available immune-based devices for detecting multiple drugs (1000 ng mL-1). Urine samples from drug addicts have been collected to verify the platform's effectiveness. By combining efficiency and accuracy, our platform offers a promising solution for addressing the challenges posed by NPSs in drug abuse detection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, National Taiwan University, Taipei 10617, Taiwan.
- Forensic and Clinical Toxicology Center National Taiwan University College of Medicine and National Taiwan University Hospital, Taipei 10051, Taiwan.
- Department and Graduate Institute of Forensic Medicine, College of Medicine, National Taiwan University, Taipei 10051, Taiwan.
- Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei 10051, Taiwan.
- Kunming Prevention and Control Center, Taipei City Hospital, Taipei 108203, Taiwan.
- Leeuwenhoek Laboratories Co. Ltd., No. 71, Fanglan Rd, Taipei, 106038, Taiwan.
ORCID-Profile: Wei-Hsin Hsu, Kai-Wen Cheng, Cheng-Chih Hsu
Förderung
- National Taiwan University Hospital
- Ministry of Science and Technology, Taiwan
- Taipei City Hospital
Zitieren
APA
Hsu, W. H., Cheng, K. W., Feng, T. H., Chen, J. Y., Chen, G. Y., Chen, L. Y., Weng, T. I., & Hsu, C. C. (2024). Rapid Screening of New Psychoactive Substances Using pDART-QqQ-MS. Journal of the American Society for Mass Spectrometry. https://doi.org/10.1021/jasms.4c00124
Vancouver
Hsu WH, Cheng KW, Feng TH, Chen JY, Chen GY, Chen LY, et al. Rapid Screening of New Psychoactive Substances Using pDART-QqQ-MS. Journal of the American Society for Mass Spectrometry. 2024. doi:10.1021/jasms.4c00124
BibTeX
@article{Hsu2024,
author = {Hsu, Wei-Hsin and Cheng, Kai-Wen and Feng, Tzu-Hsuan and Chen, Ju-Yu and Chen, Guan-Yuan and Chen, Lian-Yu and Weng, Te I and Hsu, Cheng-Chih},
title = {Rapid Screening of New Psychoactive Substances Using pDART-QqQ-MS},
journal = {Journal of the American Society for Mass Spectrometry},
year = {2024},
doi = {10.1021/jasms.4c00124}
}
EUVIMED